Protocol for the Examination of Specimens From Patients With Tumors of Bone

Department of Anatomic Pathology and Molecular Genetics, Cleveland Clinic, Lerner Research Institute and Taussig Cancer Center, Ohio 44195, USA.
Archives of pathology & laboratory medicine (Impact Factor: 2.84). 04/2010; 134(4):e1-7. DOI: 10.1043/1543-2165-134.4.e1
Source: PubMed
Download full-text


Available from: Francis H Gannon
  • Source
    • "A modified version of the grading recommendations of the College of American Pathologists is shown in Table 2 (7). In this scheme, conventional chondrosarcoma is divided into Grade 1 (low), Grade II (intermediate) and Grade III (high) on the basis of cellularity and nuclear pleomorphism, as these features have been shown to correlate with prognosis [7,8]; some specific chondrosarcoma subtypes are considered high-grade (eg mesenchymal chondrosarcoma), or low-grade (clear cell chondrosarcoma) Conventional osteosarcoma and most osteosarcoma subtypes are considered high-grade with the exception of low-grade central osteosarcoma and periosteal osteosarcoma (both low-grade) and periosteal osteosarcoma (intermediate-grade)[7,9]. Most chordomas generally behave as intermediate-grade locally aggressive tumours which frequently recur and can metastasise. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This review is intended to provide histopathologists with guidelines for clinical assessment, specimen handling and diagnostic reporting of benign and malignant primary bone tumours. Information from radiology, surgical, oncology and other clinical colleagues involved in the diagnosis and treatment of primary bone tumours should be properly assessed before undertaking a structured approach to specimen handling and histological reporting. This ensures that the information needed for planning appropriate treatment of these complex tumours is provided. Consistency in diagnostic evaluation with respect to both terminology and report content facilitates liaison at multidisciplinary bone tumour meetings and collaboration between cancer units and networks, as well as providing a common database for audit of the clinical, radiological and pathological aspects of bone tumours.
    Full-text · Article · Jul 2011
  • [Show abstract] [Hide abstract]
    ABSTRACT: The classification of soft tissue tumors is based on their resemblance to normal non-neoplastic tissues and provides an indication of how the tumor will behave in the further disease course. The current article presents the principles to be considered when classifying tumors into categories and discusses additional findings to be taken into account in the diagnosis. The importance of considering combinations of findings when classifying a tumor is underscored; individual (in particular immunohistochemical) findings can be misleading. A statement on the grade of malignancy of a soft tissue tumor requires its identification as a known entity, otherwise incorrect prediction of its biological behaviour is possible. The category of “intermediate malignancy” has been added to the categories of “benign” and “malignant”, whereby locally aggressive and incidentally metastasizing tumors have been included in this new category. The staging of soft tissue tumors according to the TNM system is explained, emphasizing that one important feature compared with carcinomas is the inclusion of depth localisation and grade of malignancy.
    No preview · Article · Feb 2010 · Der Pathologe

  • No preview · Article · Mar 2010 · Radiographics
Show more